Application Deadline: Friday, 11 December 2026 | Fully funded four-year PhD studentship
| Positions | Fully funded PhD studentship (International Strategic Partnership / International Partnership PhD; number of awards not specified) |
| University | The University of Manchester, Division of Cancer Sciences; research placements at Maastricht University |
| Location | Manchester, UK, with two placements at the GROW Basic and Translational Cancer Biology group, Maastricht University (nine months in total) |
| Funding & Salary | Full tuition fees (home or international rate) and an annual stipend at the UKRI rate for four years; £5,000 per year Research Training Support Grant; £1,000 contribution towards postgraduate research travel costs. Stipend amount not specified; candidates cover relocation, visa and health surcharges |
| Start Date | October 2027 (official University of Manchester Key dates); the FindAPhD project page states September 2027 |
| Application Deadline | Friday, 11 December 2026 |
| How to Apply | Contact the primary supervisor before applying; apply online selecting “PhD International Partnership Studentship”; submit a CV, supporting statement, academic certificates and transcripts, and two references |
Scholarship Description:
This International Strategic Partnership PhD project, “Protecting the Thymus in Lung Cancer Radiotherapy, Using Imaging, Machine Learning and Causal Inference”, is offered at The University of Manchester with research placements at Maastricht University. The supervisors listed on the project page are Prof Corinne Faivre-Finn, Dr Gareth Price, Dr Alan McWilliam and Prof Hugo Aerts.
Radiotherapy followed by immunotherapy is a key curative treatment for lung cancer. Recent studies show that preserved thymic health is associated with lower mortality and better response to immunotherapy, raising the possibility of also sparing the thymus during radiotherapy. The project will use large datasets of patients treated with radiotherapy for lung cancer in Manchester to validate the relationship between thymic dose and outcomes (distant metastasis, overall survival) in a diverse real-world cohort, examine how comorbidities – particularly cardiopulmonary and autoimmune disease – affect vulnerability to thymic dose, test whether thymic health and radiation exposure predict benefit from immunotherapy, and strengthen causal evidence using target trial emulation and mediation analysis.
The student will gain expertise in medical image analysis, machine learning and causal inference, join the Radiotherapy Related Research group in Manchester, and spend two placements at the GROW Basic and Translational Cancer Biology group in Maastricht, lasting nine months in total. Travel and accommodation support is available, and training and conference opportunities are offered throughout the PhD.
The official University of Manchester Faculty of Biology, Medicine and Health page states that applications for 2027/28 entry are open until Friday, 11 December 2026, that the studentships are fully funded for four years, and that they cover an annual stipend at the UKRI rate, tuition fees at the home or international rate, a £5,000 per year Research Training Support Grant and a £1,000 contribution towards postgraduate research travel costs. Candidates must cover relocation and associated costs such as visa and health surcharges.
On the start date, the official University Key dates section says “Studentships begin: October 2027”, while the FindAPhD project funding notes say “four years starting in September 2027”. We report the official university date and flag this discrepancy; applicants should confirm the start date with the programme.
Available Subjects:
- Medical image analysis, machine learning and causal inference in lung cancer radiotherapy.
- Thymic dose and outcomes (distant metastasis, overall survival) in real-world radiotherapy cohorts.
- Comorbidities (cardiopulmonary and autoimmune disease) and vulnerability to thymic dose.
- Target trial emulation and mediation analysis; thymus-sparing radiotherapy strategies and immunotherapy patient selection.
Eligibility criteria:
- A First or Upper Second-Class UK honours degree (or international equivalent) in physics, computer science, mathematics, statistics, data science or a related discipline; given the competitive scheme, many successful applicants also hold a Master’s qualification or relevant research experience.
- Programming, imaging or machine learning experience is desirable but not essential; research experience handling medical data (including imaging), survival analysis or machine learning is desirable.
- Applicants must be prepared to work in Maastricht for part of the PhD.
- Applicants offered a place must meet the University’s English language requirements before commencing their studies.
- The studentships are open to both home/UK and overseas/international candidates.
Application Procedure:
Candidates must contact the primary supervisor before applying to discuss their interest in the project and assess suitability. Apply online, selecting PhD International Partnership Studentship as the programme of study. Up to two projects may be applied for, each requiring a separate application with a supporting statement tailored to that project.
Include a Curriculum Vitae (CV), a supporting statement, academic certificates and transcripts, and two references. References do not need to be received by the application deadline but should be provided as soon as possible; incomplete or late applications will not be considered.
Further details: International Partnership PhD studentships (University of Manchester) and the FindAPhD project page.
Explore More Funded Opportunities:


